Results

Total Results: 903 records

Showing results for "choice".

  1. effectivehealthcare.ahrq.gov/sites/default/files/study-size-planning-chapter-9.pptx
    January 01, 2013 - Slide 1 Study Size Planning for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Study Size Planning for Observational Comparative Effectiveness Research This slide set is based on a user guide titled Developing a Protocol for Observation…
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - The choice between PCI and CABG is most relevant for patients whose coronary artery disease (CAD) lies
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - Layout 1 Oral Diabetes Medications for Adults With Type 2 Diabetes. An Update Executive Summary Effective Health Care Comparative Effectiveness Review Number 27 Effective Health Care Background Type 2 diabetes is a common chronic illness characterized by insulin resistance and eventually by decreased insulin …
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
    October 01, 2014 - treatment response evaluation for metastatic breast cancer, answers ranged from every 2-4 months to choice
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
    August 01, 2012 - for nitrous oxide for the management of labor pain Preference for Pain Management Methods Choice
  6. S149 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
    October 01, 2007 - This choice can lead to unstable estimates due to small sample sizes, especially for skewed data such
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_white-paper.pdf
    September 01, 2013 - To simplify the choice, an organization may wish to consider the advantages and disadvantages of creating
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
    August 01, 2012 - 1 Comparative Effectiveness Review Number 65 Interventions for Adolescents and Young Adults With Autism Spectrum Disorders Executive Summary Background Autism Spectrum Disorders (ASD) are among the most common neurodevelopmental disorders, with an estimated prevalence of 1 in 110 children in the United Stat…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - In the former, practitioners move to another therapeutic choice and in the latter, study subjects drop
  10. effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
    March 29, 2016 - Peer Reviewer #6 Discussion For the testing section there should be some acknowledgement that the choice … Should that guide our treatment choice?
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-212-urinary-incontinence-disposition-comments.pdf
    August 08, 2018 - The choice of a P value of 0.05 is standard, but arbitrary. … We agree that this is not the best choice of comparisons to make the point about patient preferences
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fetal-surgery_disposition-comments.pdf
    July 05, 2011 - information regarding the lack of randomized trials making direct comparisons of techniques to inform choice … Peer Reviewer #11 Results emotional “turmoil” is not the best word choice; “burden” might be better … A better word choice would be “to continuously improve and asses the quality of outcomes.”
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
    February 28, 2025 - Our choice of outcomes for this systematic review was informed by our conversations with the Technical
  14. S143 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - addition, a collection of less explicit character- istics of both the patient and prescriber influence the choice
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
    June 01, 2012 - assess a body of evidence evaluating diagnostic test outcomes (e.g., diagnostic thinking, therapeutic choice … assess a body of evidence evaluating diagnostic test outcomes—such as diagnostic thinking, therapeutic choice … and transparent system of grading using the discussed domains Giving an explicit rationale for the choice
  16. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
    June 01, 2012 - assess a body of evidence evaluating diagnostic test outcomes (e.g., diagnostic thinking, therapeutic choice … assess a body of evidence evaluating diagnostic test outcomes—such as diagnostic thinking, therapeutic choice … and transparent system of grading using the discussed domains Giving an explicit rationale for the choice
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
    March 01, 2012 - The 3 factors most influencing their choice of agents: efficacy in reducing VTE risk (83%), bleeding
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_executive.pdf
    September 01, 2012 - The Statin Choice decision aid in primary care: a randomized trial. … Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial … Further exploration of the statin choice randomized trial results. … Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
    January 01, 2014 - This guideline stated that metronidazole remains the choice for mild- moderate disease but may not … This guideline stated that metronidazole remains the choice for mild- moderate disease but may not … This guideline stated that metronidazole remains the choice for mild- moderate disease but may not … This guideline stated that metronidazole remains the choice for mild- moderate disease but may not
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research-2013.pdf
    January 01, 2013 - ............................................................................................... 6 ChoiceChoice of Priors Lu and Ades assume a noninformative prior on each parameter, in order to let the data … informative Wishart priors in a sensitivity analysis.   8 Decisionmaking Regarding Bayesian model choice … our data are sparse, heterogeneous variance assumption, a feature of CBRE1 and ABRE1, is not a good choice

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: